Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation

Liver Transplantation

Volumn 9, Issue 2, 2003, Pages 144-149

  St Peter, Shawn D ^a   Post, David J ^a   Rodriguez Davalos, Manuel I ^a   Douglas, David D ^a   Moss, Adyr A ^a   Mulligan, David C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CALCINEURIN INHIBITOR; CYCLOSPORIN; PLACEBO; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ALLOGRAFT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENDER; HUMAN; ION TRANSPORT; LABORATORY DIAGNOSIS; LIVER CELL DAMAGE; LIVER DISEASE; LIVER FUNCTION; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

EID: 0037320839     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50018     Document Type: Article

References (25)

1. Currin RT, Caldwell-Kenkel JC, Lichtman SN, Bachmann S, Takei Y, Kawano S, et al. Protection by Carolina rinse solution, acidotic pH, and glycine against lethal reperfusion injury to sinusoidal endothelial cells of rat livers stored for transplantation. Transplantation 1996;62:1549-1558.
2. Sanchez-Urdazpal L, Gores GJ, Lemasters JJ, Thurman RG, Steers JL, Wahlstrom HE, et al. Carolina rinse solution decreases liver injury during clinical liver transplantation. Transplant Proc 1993;25:1574-1575.
3. Viebahn R, Metzdorf B, de Groot H, Lauchart W. Simulation of hypoxic and preservation injury in human hepatocyte cultures: Influence of FK 506 and cyclosporine. Transplant Proc 1993;25:2691-2692.
4. Kawano K, Bowers JL, Clouse ME. Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: Influence on hepatic microcirculation. Transplant Proc 1995;27:362-363.
5. Takada Y, Fukunaga K, Taniguchi H, Yuzawa K, Otsuka M, Fukao K. Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK 506 and platelet activating factor antagonist. Transplant Proc 1996;30:3694-3695.
6. Jin MB, Yamagishi H, Ochiai T, Matsuda T, Shimizu Y, Sonoyama T, Oka T. Protective effect of FK 506 on hepatic energy metabolism in warm ischemic canine livers induced by total hepatic vascular exclusion. Transplant Proc 1998;28:1108-1110.
7. Kim YI, Akizuki S, Kawano K, Goto S, Shimada T. FK 506 prevents warm ischemia damage to the pig liver and improves hepatic microcirculation. Transplant Proc 1994;26:2384-2387.
8. Soda Y, el-Assal ON, Yu L, Nagasue N. Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine. Surgery 1999;125:23-32.
9. Kaibori M, Sakitani K, Oda M, Kamiyama Y, Masu Y, Nishizawa M, et al. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol 1999;30:1138-1145.
10. LeMasters JJ, Thurman R. Hypoxia and reperfusion injury to liver. Prog Liver Dis 1993;11:85-114.
11. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-978.
12. Schanne FA, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: A final common pathway. Science 1979;206:700-702.
13. Kumar Dhar D, Takemoto Y, Nagasue N, Uchida M, Ono T, Nakamura T. FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. J Surg Res 1996;60:142-146.
14. Schroeder RA, Kuo PC. Local consequences of reperfusion following transplantation. In: Grace PA, Mathie RT (eds). Ischaemia-reperfusion injury. London: Blackwell, 1999:113-122.
15. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: The critical injury in cold preservation of liver allografts in the rat. Transplantation 1988;46:178-191.
16. Sakr MF, Zetti GM, Hassanein TI, Farghali H, Nalesnik MA, Gavaler JS, et al. FK506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991;13:947-951.
17. Kaibori M, Inoue T, Tu W, Oda M, Kwon A-H, Kamiyama Y, et al. FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Life Sci 2001;69:17-26.
18. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994;74:336-343.
19. Garcia-Criado FJ, Palma-Vargas JM, Valdunciel-Garcia JJ, Toledo AH, Misawa K, Gomez-Alonso A, et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997;64:594-598.
20. Ohmori M, Kobayashi E, Harada K, Kitoh Y, Mizuta K, Uchida H, et al. Do immunosuppressants directly affect neutrophils, resulting in protection of the liver against ischemia-reperfusion injury? Transplantation 1998;66:940-941.
21. Okamoto S, Mukaida N, Yasumoto K, Rice N, Ishikawa Y, Horiguchi H, et al. The interleukin-8, AP1 and κB-like sites are genetic and targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 1994;269:8582-8589.
22. Squadrito F, Altavilla D, Squadrito G, Saitta A, Deodato B, Arlotta M, et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury. J Mol Cell Cardiol 2000;32:429-440.
23. Garcia-Criado FJ, Lozano-Sanchez F, Fernandez-Regalado JF, Valdunciel-Garcia JJ, Parreno-Manchado F, Silva-Benito I, et al. Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. Transplantation 1998;66:942-943.
24. Sakr MF, McClain CJ, Gavaler JS, Zetti GM, Starzl TE, Van Thiel DH. FK506 pretreatment is associated with reduced levels of tumor necrosis factor and interleukin-6 following hepatic ischemia/reperfusion. J Hepatol 1993;17:301-307.
25. Kawano K, Kim YI, Kai T, Ishii T, Tatsuma T, Morimoto A, et al. Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: In vivo demonstration for suppression of TNF-α production in response to endotoxemia. Eur Surg Res 1994;26:108-115.